Therapeutic agents for pancreatic cancer
AssigneesNational Cancer Center, Chugai Seiyaku Kabushiki Kaisha
InventorsShuichi MITSUNAGA, Atsushi OCHIAI, Masafumi IKEDA
Life of this patent
Estimating the term…
Abstract
We achieved the present invention on the basis of the finding that an excellent therapeutic effect against pancreatic cancer can be obtained by administering an IL-6 inhibitor and an antimetabolite to pancreatic cancer patients. We also found that metastatic lesions from human pancreatic cancer can be reduced and ascites can be eliminated.
Claims14
A therapeutic composition for pancreatic cancer comprising an IL-6 inhibitor, said composition further comprising an antimetabolite or being administered in combination with an antimetabolite.
A method for treating pancreatic cancer comprising the step of administering an IL-6 inhibitor and an antimetabolite to a subject.
Dependencies are inferred from the claim text.